MedPath

The analysis of the impact of basal insulin stabiity on day-by-day blood glucose variability

Not Applicable
Conditions
Type 2 diabetes
Registration Number
JPRN-UMIN000020486
Lead Sponsor
Division of Diabetes, Metabolism and Endocrinology, Jikei University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
16
Inclusion Criteria

Not provided

Exclusion Criteria

1) severe ketosis, coma, or reduced level of con- sciousness due to diabetes within the past 6 months 2) Patients who may have been pregnant or pregnant women 3) Patients with abnormal aspartate aminotransferase/alanine aminotransferase elevation (3 X the upper limit of normal) 4) Patients with moderate or severe renal dysfunction (BUN more than 25mg/dL or serum creatinine more than 2.0 mg/dL)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The average of 2 times of mean of daily differences (MODD)
Secondary Outcome Measures
NameTimeMethod
Day-by-day variability of fasting blood glucose
© Copyright 2025. All Rights Reserved by MedPath